Home > Nanotechnology Columns > Bergeson & Campbell, P.C. > EC Scientific Committee Requests Information on Nanosilver
 |
Lynn L. Bergeson Managing Director Bergeson & Campbell, P.C. |
Abstract:
On April 10, 2012, the European Commission (EC) Scientific Committee on Emerging and Newly Identified Health Risks (SCENIHR) invited interested parties to submit any relevant information that could assist it with its assessment of the safety, health, and environmental effects of nanosilver.
April 12th, 2012
EC Scientific Committee Requests Information on Nanosilver
On April 10, 2012, the European Commission (EC) Scientific Committee on Emerging and Newly Identified Health Risks (SCENIHR) invited interested parties to submit any relevant information that could assist it with its assessment of the safety, health, and environmental effects of nanosilver. See http://ec.europa.eu/health/scientific_committees/consultations/calls/scenihr_call_info_12_en.htm In particular, SCENIHR states it is interested in receiving any scientific information related to the "nano" forms of silver. The EC requested on December 9, 2011, that SCENIHR prepare a scientific opinion on the safety, health, and environmental effects and role in antimicrobial resistance of nanosilver. The EC requested SCENIHR "to assess whether the use of nanosilver, in particular in medical care and in consumer products could result in additional risks compared to more traditional uses of silver," and "to assess whether the use of nanosilver to control bacterial growth could result in resistance of micro-organisms." The deadline for SCENIHR's opinion is early 2013. All information submitted to SCENIHR is considered public unless otherwise stated by the provider. Information is due to SCENIHR June 4, 2012.
Bookmark:
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||